Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. 2009 Jun; 23(6):1054-61.